Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 5, 2025International Journal of Innovative Technologies in Social ScienceOpen Access

SUZETRIGINE, A NEW SELECTIVE NaV1.8 INHIBITOR, AS A BREAKTHROUGH IN THE TREATMENT OF PAIN – A REVIEW ARTICLE

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMałgorzata KrzyżanowskaKKKatarzyna KozonKKKatarzyna Krupa

Discussion

Loading...

Member takes

Overview

Review evaluates suzetrigine's efficacy in managing pain and its potential as a non-opioid alternative, suggesting significant therapeutic promise.

Key Points

  • Suzetrigine is a novel NaV1.8 inhibitor showing potential in managing pain effectively.
  • The review highlights suzetrigine's selectivity, minimizing off-target effects common with other sodium channel blockers.
  • Comprehensive literature review identified suzetrigine as a promising candidate for pain management strategies.
  • Findings suggest that suzetrigine could be a breakthrough in analgesia, especially for postoperative pain relief.

Cite This Study

Krzyżanowska et al. (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d138chttps://doi.org/10.31435/ijitss.3(47).2025.3482
View Full Paper
Ask AI
Bookmark
Share